Developer docs
API playgroundTry for free, no card

Search company profiles

VIRCELL

Full company profile

uuid000aki2

Namestring
VIRCELL
Legal namestring
Vircell, S.L.
Websiteurl
vircell.com
Company typeenum
Private
Founded yearint
1994
Descriptiontext

Vircell, S.L. is a privately held Spanish biotechnology company headquartered in the Parque Tecnológico de la Salud in Granada, founded in the mid-1990s, that develops, manufactures, and sells ready-to-use diagnostic reagents for human infectious diseases. Its portfolio is organized into two divisions — Vircell Microbiologists (serology) and Vircell Molecular (molecular diagnostics) — covering more than 500 catalog references for the detection of bacteria, viruses, parasites, and fungi across 15+ disease categories using ELISA, chemiluminescence, direct and indirect immunofluorescence, immunocapture, real-time PCR, PCR controls, and cell culture techniques.

The serological line is anchored by the VirClia® Monotest reagent family and the VirClia® Lotus fully automated continuous-load random-access CLIA analyzer capable of running 90+ infectious markers in monotest format. The molecular line comprises the VIRCOM real-time PCR kits, VIRPLEX extraction and RT-PCR kits, VIRCOM MINILAB compact instrument, and the AMPLIRUN® line of independent molecular controls. Registered trademarks (VirClia®, AmpliRun®, Brucellacapt®, VIRCOM, VIRPLEX) and specialized products such as Brucellacapt® for brucellosis immunocapture testing define a number of defensible niche positions.

Vircell operates a B2B sales-led go-to-market, selling reagents and instruments directly to clinical microbiology and molecular diagnostic laboratories through dedicated national and international commercial teams, reaching more than 90 countries across five continents. The company is ISO 13485:2016 certified (TÜV SÜD), holds Esquema Nacional de Seguridad certification, and is in the process of certifying its catalog under the EU IVDR, with Class A non-sterile products compliant since May 2022 and Class B and C products certified as of October 2024. No pricing is publicly disclosed and no revenue, funding, or customer concentration data is available in the source material.

Short descriptiontext

Vircell is a privately held Spanish biotechnology company that develops and manufactures ready-to-use diagnostic reagents and instruments for human infectious disease testing, selling through direct sales teams to clinical laboratories in more than 90 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersGranada, Spain
HQ citystring
Granada
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
infectious disease diagnostics, diagnostic reagents, molecular diagnostics, serological testing, in vitro diagnostics
Industry3 codes
1IVD Reagents, Assay Kits & Consumables (Non-instrument)
CodeHLAHAAAMPrimaryYes
2Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels)
CodeHLAAALACPrimaryNo
3Microbiology & Infectious Disease Diagnostics (Culture/ID/AST)
CodeHLAHAAACPrimaryNo
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
In Vitro Diagnostics (IVD) Reagents and Kits
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Diagnostic Reagents and Kits
TypeOne Time License
Description

Vircell generates revenue through the sale of ready-to-use diagnostic reagents for serological and molecular techniques used in human infectious disease diagnosis. The product portfolio includes over 500 catalog references covering bacteria, viruses, parasites, and fungi detection.

vircell.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1VirClia® Monotest
Description

CLIA chemiluminescence monotest for infectious disease diagnosis

vircell.com
+6 more records
Core offering1 text field

Vircell, S.L. develops, manufactures, and sells ready-to-use diagnostic reagents, kits, and instruments for the detection of infectious diseases in humans. The portfolio spans two divisions — Vircell Microbiologist (serological techniques: ELISA, chemiluminescence, indirect and direct immunofluorescence, immunocapture, rapid tests, cell culture, transport media) and Vircell Molecular (Real Time PCR kits, extraction reagents, independent molecular controls, and compact PCR instruments). The company offers more than 500 catalog references covering bacteria, viruses, parasites, and fungi, distributed to clinical laboratories in over 90 countries.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

VIRCELL is a biotechnology company specializing in the development and production of ready-to-use diagnostic reagents for infectious diseases in humans. The portfolio consists of two main divisions: Vircell Microbiologist (serological products) and Vircell Molecular (molecular biology products). The serological line includes VirClia® Monotest, VirClia® Lotus automated CLIA analyzer, ELISA, IFA (Indirect Immunofluorescence), DFA (Direct Immunofluorescence), Brucellacapt®, Rose Bengal, rapid tests, cell lines, and transport media. The molecular line includes VIRCOM PCR kits, VIRPLEX extraction and RT-PCR kits, VIRCOM MINILAB, AmpliRun® molecular controls (including AmpliRun® Total), and molecular instruments. The company offers over 500 product references covering bacteria, viruses, parasites, and fungi detection using serological and molecular techniques. Products are available in over 90 countries worldwide.

Product and service18 records
1VirClia® Monotest
2VirClia® Lotus
3ELISA Reagents
4IFA (Indirect Immunofluorescence) Reagents
5DFA (Direct Immunofluorescence) Reagents
6Brucellacapt®
7Rosa de Bengala (Rose Bengal)
8Pruebas Rápidas (Rapid Diagnostic Tests)
9VIRCOM PCR Kits
10VIRPLEX RT-PCR Kits
11VIRPLEX Extraction Reagents
12AmpliRun® Molecular Controls
13AmpliRun® Total Molecular Controls
14VIRCOM MINILAB
15Líneas Celulares (Cell Lines)
16Medios de Transporte (Viral Transport Media)
17Instrumentos VirClia®
18Instrumentos Biología Molecular (Molecular Biology Instruments)
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2023-10-18
Description

TÜV SÜD Product Service GmbH serves as Vircell's Notified Body for IVDR conformity assessment and ISO 13485 quality management system certification. As of October 18, Vircell obtained certification necessary to CE-mark Class B and C products under IVDR through this partnership.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global leader in microbiology and infectious disease diagnostics, offering serology, molecular, and culture-based IVD reagents and instruments to clinical laboratories. Highly comparable to Vircell across product category, customer base, and commercial model, though materially larger and more diversified.

TypeDirect peer
Description

Established IVD manufacturer with a broad infectious disease serology and molecular controls portfolio serving clinical laboratories worldwide. Direct overlap with Vircell in ELISA, molecular controls, and quality assurance reagents for microbiology.

TypeDirect peer
Description

Specialist in CLIA-based serological diagnostics with a strong infectious disease menu and proprietary LIAISON analyzer family. Closely comparable to Vircell on the VirClia Lotus / chemiluminescence serology side, serving the same clinical lab customers.

TypeDirect peer
Description

US-based specialty IVD company focused on gastrointestinal, respiratory, and other infectious disease diagnostics, with both molecular and immunoassay products. Comparable to Vircell as a mid-sized infectious-disease-focused reagent manufacturer.

TypeBroad incumbent
Description

Large diversified diagnostics player offering infectious disease rapid tests, molecular assays, and specialty immunoassays. Operates across broader portfolios than Vircell but is a direct competitor in select infectious disease serology and rapid test categories.

TypeBroad incumbent
Description

Major molecular diagnostics company with a strong infectious disease franchise (e.g., Panther system, Aptima assays). A competitor in the molecular infectious disease IVD space where Vircell's VIRCOM and VIRPLEX kits also compete for lab adoption.

TypeDirect peer
Description

European-headquartered specialty IVD company producing molecular diagnostics kits (PCR) and clinical chemistry reagents for clinical laboratories. Closely comparable mid-sized competitor with overlapping customer base and product focus.

TypeDirect peer
Description

German specialty diagnostics manufacturer offering IVD reagents across clinical chemistry, microbiology, and food/feed testing, including PCR-based infectious disease kits. Comparable mid-sized European IVD reagent company with similar product breadth and lab customer focus.

TypeBroad incumbent
Description

Global IVD manufacturer with serology, clinical chemistry, and rapid test portfolios serving clinical laboratories. Competes with Vircell in infectious disease serology and rapid testing, with a larger overall portfolio and broader commercial reach.

TypeOthers
Description

Laboratory automation and detection instrument manufacturer whose readers and automated platforms can be used alongside IVD reagent workflows. Comparable to Vircell as a laboratory instrumentation supplier to the same clinical lab customers.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

VIRCELL

In Vitro Diagnostics (IVD) Reagents and Kitsvircell.com

Vircell is a privately held Spanish biotechnology company that develops and manufactures ready-to-use diagnostic reagents and instruments for human infectious disease testing, selling through direct sales teams to clinical laboratories in more than 90 countries.

What VIRCELL does

Vircell, S.L. is a privately held Spanish biotechnology company headquartered in the Parque Tecnológico de la Salud in Granada, founded in the mid-1990s, that develops, manufactures, and sells ready-to-use diagnostic reagents for human infectious diseases. Its portfolio is organized into two divisions — Vircell Microbiologists (serology) and Vircell Molecular (molecular diagnostics) — covering more than 500 catalog references for the detection of bacteria, viruses, parasites, and fungi across 15+ disease categories using ELISA, chemiluminescence, direct and indirect immunofluorescence, immunocapture, real-time PCR, PCR controls, and cell culture techniques.

The serological line is anchored by the VirClia® Monotest reagent family and the VirClia® Lotus fully automated continuous-load random-access CLIA analyzer capable of running 90+ infectious markers in monotest format. The molecular line comprises the VIRCOM real-time PCR kits, VIRPLEX extraction and RT-PCR kits, VIRCOM MINILAB compact instrument, and the AMPLIRUN® line of independent molecular controls. Registered trademarks (VirClia®, AmpliRun®, Brucellacapt®, VIRCOM, VIRPLEX) and specialized products such as Brucellacapt® for brucellosis immunocapture testing define a number of defensible niche positions.

Vircell operates a B2B sales-led go-to-market, selling reagents and instruments directly to clinical microbiology and molecular diagnostic laboratories through dedicated national and international commercial teams, reaching more than 90 countries across five continents. The company is ISO 13485:2016 certified (TÜV SÜD), holds Esquema Nacional de Seguridad certification, and is in the process of certifying its catalog under the EU IVDR, with Class A non-sterile products compliant since May 2022 and Class B and C products certified as of October 2024. No pricing is publicly disclosed and no revenue, funding, or customer concentration data is available in the source material.

VIRCELL firmographics

Firmographics
Name
VIRCELL
Legal name
Vircell, S.L.
Website
https://vircell.com
Company type
Private
Founded year
1994
Operating status
Operating
Headcount range
101–250 employees
Short description
Vircell is a privately held Spanish biotechnology company that develops and manufactures ready-to-use diagnostic reagents and instruments for human infectious disease testing, selling through direct sales teams to clinical laboratories in more than 90 countries.
Ownership category
akta.pro rank

VIRCELL industry classification

Industry
Product category
In Vitro Diagnostics (IVD) Reagents and Kits
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)
akta.pro secondary industries
Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC), Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC)

Keywords

  • Infectious disease diagnostics
  • Diagnostic reagents
  • Molecular diagnostics
  • Serological testing
  • In vitro diagnostics

Where VIRCELL is headquartered

Location

Headquarters

HQ city
Granada
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

VIRCELL business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Diagnostic Reagents and Kits: Vircell generates revenue through the sale of ready-to-use diagnostic reagents for serological and molecular techniques used in human infectious disease diagnosis. The product portfolio includes over 500 catalog references covering bacteria, viruses, parasites, and fungi detection.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

VIRCELL product offering

Product offering

Core offering

Vircell, S.L. develops, manufactures, and sells ready-to-use diagnostic reagents, kits, and instruments for the detection of infectious diseases in humans. The portfolio spans two divisions — Vircell Microbiologist (serological techniques: ELISA, chemiluminescence, indirect and direct immunofluorescence, immunocapture, rapid tests, cell culture, transport media) and Vircell Molecular (Real Time PCR kits, extraction reagents, independent molecular controls, and compact PCR instruments). The company offers more than 500 catalog references covering bacteria, viruses, parasites, and fungi, distributed to clinical laboratories in over 90 countries.

Product overview

VIRCELL is a biotechnology company specializing in the development and production of ready-to-use diagnostic reagents for infectious diseases in humans. The portfolio consists of two main divisions: Vircell Microbiologist (serological products) and Vircell Molecular (molecular biology products). The serological line includes VirClia® Monotest, VirClia® Lotus automated CLIA analyzer, ELISA, IFA (Indirect Immunofluorescence), DFA (Direct Immunofluorescence), Brucellacapt®, Rose Bengal, rapid tests, cell lines, and transport media. The molecular line includes VIRCOM PCR kits, VIRPLEX extraction and RT-PCR kits, VIRCOM MINILAB, AmpliRun® molecular controls (including AmpliRun® Total), and molecular instruments. The company offers over 500 product references covering bacteria, viruses, parasites, and fungi detection using serological and molecular techniques. Products are available in over 90 countries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

  • VirClia® Monotest: CLIA chemiluminescence monotest for infectious disease diagnosis
  • VirClia® Lotus
  • AMPLIRUN®
  • AMPLIRUN® Total
  • VIRCOM
  • VIRPLEX
  • Brucellacapt®

Products and services

  • VirClia® Monotest
  • VirClia® Lotus
  • ELISA Reagents
  • IFA (Indirect Immunofluorescence) Reagents
  • DFA (Direct Immunofluorescence) Reagents
  • Brucellacapt®
  • Rosa de Bengala (Rose Bengal)
  • Pruebas Rápidas (Rapid Diagnostic Tests)
  • VIRCOM PCR Kits
  • VIRPLEX RT-PCR Kits
  • VIRPLEX Extraction Reagents
  • AmpliRun® Molecular Controls
  • AmpliRun® Total Molecular Controls
  • VIRCOM MINILAB
  • Líneas Celulares (Cell Lines)
  • Medios de Transporte (Viral Transport Media)
  • Instrumentos VirClia®
  • Instrumentos Biología Molecular (Molecular Biology Instruments)

Companies that use VIRCELL

Customer profile

Segments1 record

Ideal customer profiles2 records

VIRCELL technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

VIRCELL partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • TÜV SÜD Product Service GmbHcoreImplementation/ SI/ Consulting Partner · 18 October 2023TÜV SÜD Product Service GmbH serves as Vircell's Notified Body for IVDR conformity assessment and ISO 13485 quality management system certification. As of October 18, Vircell obtained certification necessary to CE-mark Class B and C products under IVDR through this partnership.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

VIRCELL competitors and assessment

Company assessment

Direct peers

  • bioMérieux: Global leader in microbiology and infectious disease diagnostics, offering serology, molecular, and culture-based IVD reagents and instruments to clinical laboratories. Highly comparable to Vircell across product category, customer base, and commercial model, though materially larger and more diversified.
  • Bio-Rad Laboratories: Established IVD manufacturer with a broad infectious disease serology and molecular controls portfolio serving clinical laboratories worldwide. Direct overlap with Vircell in ELISA, molecular controls, and quality assurance reagents for microbiology.
  • DiaSorin: Specialist in CLIA-based serological diagnostics with a strong infectious disease menu and proprietary LIAISON analyzer family. Closely comparable to Vircell on the VirClia Lotus / chemiluminescence serology side, serving the same clinical lab customers.
  • Meridian Bioscience: US-based specialty IVD company focused on gastrointestinal, respiratory, and other infectious disease diagnostics, with both molecular and immunoassay products. Comparable to Vircell as a mid-sized infectious-disease-focused reagent manufacturer.
  • ELITech Group: European-headquartered specialty IVD company producing molecular diagnostics kits (PCR) and clinical chemistry reagents for clinical laboratories. Closely comparable mid-sized competitor with overlapping customer base and product focus.
  • R-Biopharm: German specialty diagnostics manufacturer offering IVD reagents across clinical chemistry, microbiology, and food/feed testing, including PCR-based infectious disease kits. Comparable mid-sized European IVD reagent company with similar product breadth and lab customer focus.

Broad incumbents

  • QuidelOrtho: Large diversified diagnostics player offering infectious disease rapid tests, molecular assays, and specialty immunoassays. Operates across broader portfolios than Vircell but is a direct competitor in select infectious disease serology and rapid test categories.
  • Hologic: Major molecular diagnostics company with a strong infectious disease franchise (e.g., Panther system, Aptima assays). A competitor in the molecular infectious disease IVD space where Vircell's VIRCOM and VIRPLEX kits also compete for lab adoption.
  • Sekisui Diagnostics: Global IVD manufacturer with serology, clinical chemistry, and rapid test portfolios serving clinical laboratories. Competes with Vircell in infectious disease serology and rapid testing, with a larger overall portfolio and broader commercial reach.

Others

  • Tecan: Laboratory automation and detection instrument manufacturer whose readers and automated platforms can be used alongside IVD reagent workflows. Comparable to Vircell as a laboratory instrumentation supplier to the same clinical lab customers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

VIRCELL social profiles

Digital presence

VIRCELL compliance and trust

Trust signal

Compliance3 records

VIRCELL financial estimates

Financial estimate

Revenue estimate

Valuation estimate

VIRCELL leadership team

Management profile

Number of profiles

VIRCELL funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

VIRCELL M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VIRCELL

What does VIRCELL do?

Vircell, S.L. develops, manufactures, and sells ready-to-use diagnostic reagents, kits, and instruments for the detection of infectious diseases in humans. The portfolio spans two divisions — Vircell Microbiologist (serological techniques: ELISA, chemiluminescence, indirect and direct immunofluorescence, immunocapture, rapid tests, cell culture, transport media) and Vircell Molecular (Real Time PCR kits, extraction reagents, independent molecular controls, and compact PCR instruments). The company offers more than 500 catalog references covering bacteria, viruses, parasites, and fungi, distributed to clinical laboratories in over 90 countries.

Is VIRCELL a public or private company?

VIRCELL is a private company. It is classified as unknown and is currently operating.

When was VIRCELL founded?

VIRCELL was founded in 1994. It employs 101 to 250 people.

Where is VIRCELL based?

VIRCELL is headquartered in Granada, Spain, in the Europe region.

How does VIRCELL make money?

One revenue line is on record: diagnostic Reagents and Kits.

Who are VIRCELL's main competitors?

Direct peers on record are bioMérieux, Bio-Rad Laboratories, DiaSorin, Meridian Bioscience, ELITech Group and R-Biopharm. Broad incumbents are QuidelOrtho, Hologic and Sekisui Diagnostics. Tecan is listed as an others.

Does VIRCELL have an API?

No public API is recorded for VIRCELL.

What industry is VIRCELL in?

VIRCELL's product category is In Vitro Diagnostics (IVD) Reagents and Kits. Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAAALAC, Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales